Refeyn announces that the company’s Chief Executive Officer, Anthony Fernandez, is taking a temporary leave of absence. During this...

Response to article on mass photometer stage alignment (J Pharm Sci, Nov 2022)

Refeyn Ltd., the mass photometry pioneer, has announced the successful completion of its Series B funding round.